After the company's recent fall from grace, Amicus shares are showing new life, up double digits in late-day trading. Today's pop follows a press release announcing solid phase 2 results for one of Amicus' pipeline drugs. On the other side of the coin, today's biggest loser was a company called Accuray , a medical devices stock down some 20% today after pre-announcing quarterly results last night after the market closed.
What's inside Supernova?
If you're an investor looking for big long-term winners, Motley Fool co-founder David Gardner's picks have frequently trounced the market. How? Because he's always on the lookout for revolutionary stocks and recommends them before Wall Street catches on to their disruptive potential. If you're interested in how David discovers his winners, click here to get instant access to a personal tour behind David's Supernova service.
The article Friday's Best and Worst Health Care Stocks originally appeared on Fool.com.
Brenton Flynn and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.